Altre lingue Tus-Pharmaceutical Group Co., Ltd.

Azioni

000590

CNE000000701

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 11/06/2024			Variaz. 5gg	Var. 1 gen.
5,62 ^CNY	-1,40%		-4,26%	-37,28%

25/04	Tus-Pharmaceutical Group Co., Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
27/03	Tus-Pharmaceutical Group Co., Ltd. riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Tus Pharmaceutical to Boost Investment in Chemical Park Project	12/01
Tus-Pharmaceutical Group Co., Ltd. agreed to acquire 55% stake in Wuhan Medtek Pharmaceutical Co., Ltd. from Tan Yunliang and Wang Zhong for approximately CNY 140 million.	12/01
Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	22/08/23
Tus-Pharmaceutical Group Co., Ltd. Approves Board Appointments	19/05/23
Tus Pharmaceutical to Set Up New Marketing Subsidiary	19/05/23
Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23
Guhan Traditional Chinese Medicine Co., Ltd. announced that it expects to receive CNY 22 million in funding from Tus-Pharmaceutical Group Co., Ltd.	30/12/22
Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22
Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	29/08/22
Tus-Pharmaceutical Group Co., Ltd. completed the acquisition of Guangdong Sinotau Pharmaceutical Co., Ltd. from Beijing Xiantongyuan Pharmaceutical Technology Co., Ltd. and Li Yinqiang.	24/08/22
Tus Pharmaceutical to Buy Local Drugmaker Xiantong for $33 Million	03/08/22
Tus-Pharmaceutical Group Co., Ltd. agreed to acquire 100% stake in Guangdong Sinotau Pharmaceutical Co., Ltd. from Beijing Xiantongyuan Pharmaceutical Technology Co., Ltd. and Li Yinqiang fron CNY220 million.	03/08/22
Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	28/04/22
Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	30/03/22
Hunan Tus-Pharmaceutical Biological Co., Ltd. announced that it expects to receive CNY 25 million in funding from Tus-Pharmaceutical Group Co., Ltd., Ningbo Yiduoduo Electronic Commerce Co., Ltd.	18/01/22
Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	27/10/21
Tus-Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	27/08/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Tus-Pharmaceutical Group Co., Ltd.

Azioni

000590

CNE000000701

Altre lingue

Filtri